SCHEMBL31484256

SCHEMBL31484256

COc1ccc(CC(N)=O)c(OC)c1C=NN

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.39
▸ F2 P00734 2/20 0.35
▸ PRSS1 P07477 2/20 0.35
▸ PRSS2 P07478 2/20 0.35
▸ PRSS3 P35030 2/20 0.35
▸ LMNA P02545 3/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ ICMT O60725 1/20 0.34
▸ POLB P06746 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ CTDSP1 Q9GZU7 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ CTSD P07339 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6904741 0.80 AOC3 (0.50) MAPTLMNASMN1; SMN2MAPK1POLB
SCHEMBL31484255 0.77 KDM4E (0.42) MAPTLMNASMN1; SMN2POLBKDM4E
SCHEMBL1032325 0.72 CA12 (0.50) LMNASMN1; SMN2L3MBTL1
SCHEMBL31484258 0.70 GRIN2D (0.33) SMN1; SMN2ICMTHSD17B10
SCHEMBL28142858 0.69 HSD17B10 (0.50) MAPTLMNAMAPK1KDM4EHSD17B10
SCHEMBL1599374 0.68 CYP2C9 (0.56) MAPTLMNAICMTKDM4EHSD17B10
SCHEMBL1461671 0.67 KDM4E (0.49) MAPTSMN1; SMN2POLBKDM4ECTDSP1
SCHEMBL7151000 0.66 KDM4E (0.51) MAPTSMN1; SMN2POLBKDM4ECTDSP1
SCHEMBL1010680 0.66 LMNA (0.64) MAPTLMNASMN1; SMN2POLBKDM4E
SCHEMBL3456256 0.66 KMT2A (0.56) LMNASMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025068461-A1 GUANFACINE DERIVATIVES AND THEIR USE IN TREATING CANCER NEGIO THERAPEUTICS (BE) 2025-04-03 — — WO claimed
WO-2025068461-A1 GUANFACINE DERIVATIVES AND THEIR USE IN TREATING CANCER NEGIO THERAPEUTICS (BE) 2025-04-03 — — WO disclosed
Send feedback